Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | SMMT |
---|---|---|
09:32 ET | 354557 | 20.39 |
09:34 ET | 181293 | 20.6693 |
09:36 ET | 318966 | 21.05 |
09:38 ET | 230311 | 21.21 |
09:39 ET | 256032 | 20.67 |
09:41 ET | 199637 | 20.24 |
09:43 ET | 224155 | 19.6621 |
09:45 ET | 245227 | 20.0449 |
09:48 ET | 135198 | 20.05 |
09:50 ET | 124791 | 19.6691 |
09:52 ET | 140422 | 19.52 |
09:54 ET | 190212 | 19.13 |
09:56 ET | 121165 | 18.94 |
09:57 ET | 130455 | 18.984 |
09:59 ET | 81150 | 19.2819 |
10:01 ET | 81752 | 18.95 |
10:03 ET | 52574 | 19.05 |
10:06 ET | 123502 | 18.68 |
10:08 ET | 52243 | 18.84 |
10:10 ET | 54144 | 18.8599 |
10:12 ET | 34822 | 18.81 |
10:14 ET | 63120 | 19.16 |
10:15 ET | 33802 | 19.2092 |
10:17 ET | 112343 | 19.34 |
10:19 ET | 61410 | 19.2789 |
10:21 ET | 52209 | 18.995 |
10:24 ET | 35772 | 18.87 |
10:26 ET | 34761 | 18.84 |
10:28 ET | 28853 | 18.7999 |
10:30 ET | 92390 | 18.62 |
10:32 ET | 77444 | 18.3586 |
10:33 ET | 163349 | 18.17 |
10:35 ET | 60843 | 18.24 |
10:37 ET | 58970 | 18.51 |
10:39 ET | 26406 | 18.515 |
10:42 ET | 38088 | 18.65 |
10:44 ET | 33388 | 18.74 |
10:46 ET | 32935 | 18.66 |
10:48 ET | 29965 | 18.82 |
10:50 ET | 39427 | 18.8298 |
10:51 ET | 38679 | 19.15 |
10:53 ET | 46271 | 18.93 |
10:55 ET | 26762 | 18.96 |
10:57 ET | 11315 | 19.0295 |
11:00 ET | 37829 | 19.01 |
11:02 ET | 34402 | 19.01 |
11:04 ET | 25327 | 19.01 |
11:06 ET | 38425 | 18.92 |
11:08 ET | 26979 | 19.05 |
11:09 ET | 15356 | 18.98 |
11:11 ET | 20071 | 18.88 |
11:13 ET | 42913 | 18.7253 |
11:15 ET | 31396 | 18.7799 |
11:18 ET | 12629 | 18.68 |
11:20 ET | 32591 | 18.6 |
11:22 ET | 25535 | 18.69 |
11:24 ET | 36581 | 18.6 |
11:26 ET | 11685 | 18.6 |
11:27 ET | 32063 | 18.8455 |
11:29 ET | 27847 | 18.87 |
11:31 ET | 27689 | 18.81 |
11:33 ET | 37256 | 18.7479 |
11:36 ET | 12509 | 18.84 |
11:38 ET | 8644 | 18.95 |
11:40 ET | 30329 | 18.987939 |
11:42 ET | 16944 | 18.85 |
11:44 ET | 19061 | 18.965 |
11:45 ET | 6404 | 18.845 |
11:47 ET | 18090 | 18.81 |
11:49 ET | 6739 | 18.7601 |
11:51 ET | 8443 | 18.65 |
11:54 ET | 22398 | 18.7 |
11:56 ET | 2642 | 18.73 |
11:58 ET | 3104 | 18.775 |
12:00 ET | 17094 | 18.77 |
12:02 ET | 9261 | 18.84 |
12:03 ET | 12317 | 18.804 |
12:05 ET | 13769 | 18.88 |
12:07 ET | 16422 | 18.92 |
12:09 ET | 8741 | 18.91 |
12:12 ET | 6937 | 18.8895 |
12:14 ET | 9265 | 18.94 |
12:16 ET | 17299 | 18.972 |
12:18 ET | 11564 | 18.965 |
12:20 ET | 21740 | 18.99 |
12:21 ET | 39252 | 19.05 |
12:23 ET | 26363 | 19.0801 |
12:25 ET | 10335 | 19.11 |
12:27 ET | 26214 | 19.07 |
12:30 ET | 18532 | 18.93 |
12:32 ET | 20319 | 18.9585 |
12:34 ET | 14951 | 19.0267 |
12:36 ET | 14526 | 19.0199 |
12:38 ET | 14053 | 19.06 |
12:39 ET | 23365 | 19.1132 |
12:41 ET | 28474 | 19.092 |
12:43 ET | 11200 | 19.1026 |
12:45 ET | 4271 | 19.1234 |
12:48 ET | 12468 | 19.12 |
12:50 ET | 11709 | 19.1 |
12:52 ET | 15049 | 19.11 |
12:54 ET | 6052 | 19.1 |
12:56 ET | 4091 | 19.0635 |
12:57 ET | 5124 | 19.07 |
12:59 ET | 13700 | 18.99 |
01:01 ET | 16214 | 19.01 |
01:03 ET | 6839 | 19 |
01:06 ET | 13339 | 19.04 |
01:08 ET | 5540 | 19.01 |
01:10 ET | 6683 | 19.0186 |
01:12 ET | 10795 | 19.115 |
01:14 ET | 12239 | 19.23 |
01:15 ET | 12400 | 19.2202 |
01:17 ET | 12519 | 19.205 |
01:19 ET | 6107 | 19.18 |
01:21 ET | 5712 | 19.15 |
01:24 ET | 8909 | 19.16 |
01:26 ET | 16666 | 19.19 |
01:28 ET | 4470 | 19.1695 |
01:30 ET | 4248 | 19.135 |
01:32 ET | 5855 | 19.115 |
01:33 ET | 2383 | 19.14 |
01:35 ET | 7371 | 19.13 |
01:37 ET | 5867 | 19.1454 |
01:39 ET | 5539 | 19.08 |
01:42 ET | 6711 | 19.09 |
01:44 ET | 5588 | 19.11 |
01:46 ET | 1518 | 19.12 |
01:48 ET | 9635 | 19.1205 |
01:50 ET | 6952 | 19.1 |
01:51 ET | 3381 | 19.02 |
01:53 ET | 19461 | 19 |
01:55 ET | 1050 | 19.015 |
01:57 ET | 7314 | 19.05 |
02:00 ET | 8717 | 19.0334 |
02:02 ET | 4668 | 19.01 |
02:04 ET | 10175 | 18.98 |
02:06 ET | 8912 | 19.02 |
02:08 ET | 8986 | 19 |
02:09 ET | 8179 | 19.04 |
02:11 ET | 4547 | 19.02 |
02:13 ET | 6674 | 19.0221 |
02:15 ET | 5983 | 19.02 |
02:18 ET | 11463 | 19.01 |
02:20 ET | 4126 | 19 |
02:22 ET | 12639 | 19.02 |
02:24 ET | 13712 | 18.9901 |
02:26 ET | 11542 | 19.01 |
02:27 ET | 6390 | 19.09 |
02:29 ET | 3429 | 19.09 |
02:31 ET | 4776 | 19.0801 |
02:33 ET | 11577 | 19.07 |
02:36 ET | 7486 | 19.08 |
02:38 ET | 4596 | 19.05 |
02:40 ET | 10453 | 19.045 |
02:42 ET | 13808 | 19.11 |
02:44 ET | 15014 | 19.13 |
02:45 ET | 8304 | 19.115 |
02:47 ET | 6501 | 19.095 |
02:49 ET | 19545 | 19.045 |
02:51 ET | 26092 | 19.03 |
02:54 ET | 5689 | 19.09 |
02:56 ET | 9937 | 19.1 |
02:58 ET | 6998 | 19.12 |
03:00 ET | 19550 | 19.2229 |
03:02 ET | 12495 | 19.24 |
03:03 ET | 18143 | 19.274 |
03:05 ET | 14557 | 19.18 |
03:07 ET | 4954 | 19.245 |
03:09 ET | 6168 | 19.215 |
03:12 ET | 9222 | 19.19 |
03:14 ET | 61535 | 19.14 |
03:16 ET | 19425 | 19.2 |
03:18 ET | 13567 | 19.26 |
03:20 ET | 17498 | 19.32 |
03:21 ET | 21854 | 19.35 |
03:23 ET | 32705 | 19.34 |
03:25 ET | 20617 | 19.32 |
03:27 ET | 15860 | 19.335 |
03:30 ET | 12364 | 19.37 |
03:32 ET | 13018 | 19.29 |
03:34 ET | 42309 | 19.355 |
03:36 ET | 24190 | 19.34 |
03:38 ET | 18004 | 19.315 |
03:39 ET | 10222 | 19.295 |
03:41 ET | 22420 | 19.31 |
03:43 ET | 18942 | 19.305 |
03:45 ET | 25913 | 19.32 |
03:48 ET | 20240 | 19.29 |
03:50 ET | 38487 | 19.2999 |
03:52 ET | 36853 | 19.178 |
03:54 ET | 19489 | 19.165 |
03:56 ET | 37488 | 19.195 |
03:57 ET | 73575 | 19.08 |
03:59 ET | 312129 | 19.09 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Summit Therapeutics Inc | 13.7B | -83.1x | --- |
Vaxcyte Inc | 14.8B | -24.1x | --- |
Insmed Inc | 12.3B | -13.4x | --- |
Revolution Medicines Inc | 7.7B | -13.0x | --- |
Ascendis Pharma A/S | 8.5B | -15.1x | --- |
Viking Therapeutics Inc | 7.1B | -69.2x | --- |
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician and caregiver medicinal therapies. The Company's development candidate is ivonescimab, a potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF compound into a single molecule. It develops ivonescimab in non-small cell lung cancer (NSCLC), specifically launching Phase III clinical trials in the indications such as ivonescimab combined with chemotherapy in patients with epidermal growth factor receptor (EGFR)-mutated, locally advanced or metastatic non-squamous NSCLC who have progressed after treatment with a third-generation EGFR tyrosine kinase inhibitor (HARMONi), and ivonescimab combined with chemotherapy in first-line metastatic squamous NSCLC patients (HARMONi-3). Its ivonescimab is engineered with Akeso's Tetrabody technology.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $14.0B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 735.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.94 |
EPS | $-0.23 |
Book Value | $0.11 |
P/E Ratio | -83.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.